Drug
Sulfur Hexafluoride clinical trials
Also written Lumason and SonoVue.
- studies test it
- 38
- open now
- 10
- in phase 3
- 9
- first study started
- 2008
Keep track of what changes. Save the Sulfur Hexafluoride studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
36 studies that test it; most in 2020 (7); 2 more planned to start later
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 7 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 4 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 5
- Phase 1
- 8
- Phase 2
- 10
- Phase 3
- 9
- Phase 4
- 7
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 34
Children's Hospital of Philadelphia (6) · Bracco Diagnostics, Inc (4) · Mayo Clinic (3) · David Mooney (2) · Indiana University (2) · UNC Lineberger Comprehensive Cancer Center (2) · Milton S. Hershey Medical Center (2) · Boston Children's Hospital (2)
Often tested with
Tested in the same studies.
Perflutren (4) · FS 069 (1) · Florbetapir (1) · MK-6240 (1) · Gadoterate meglumine (1)
Studies
Open first, then newest update. How each study uses Sulfur Hexafluoride is read from its arms, and is right about nine times in ten.
Testing it · 38
- Lumason® Infusion vs. Bolus AdministrationsRecruitingPhase 3Bracco Diagnostics, IncNCT06400004Written as Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON]
- CEUS Evaluation of Hydrocephalus in Neonates and InfantsRecruitingPhase 2Children's Hospital of PhiladelphiaNCT06693752Written as Sulfur Hexafluoride Lipid Type A Microspheres 25 mg Injection Powder for Suspension [LUMASON]
- Radiation-Free Technique for Evaluating Renal Scarring (RAFTERS)Not yet recruitingPhase 1Boston Children's HospitalNCT03653702Written as Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON]
- Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and TauNot yet recruitingPhase 1Columbia UniversityNCT06600880Written as Lumason
- Intraoperative Contrast-Enhanced Ultrasound Evaluation of Blood Flow at the Time of Surgical Hip Reduction for DDHRecruitingEarly Phase 1Children's Hospital of PhiladelphiaNCT03107520Written as Lumason
- Contrast-Enhanced Ultrasound Imaging for Diagnosing Recurrent Renal Cell Carcinoma (RCC) Post AblationRecruitingPhase 2john eisenbreyNCT05641935Written as Sulfur Hexafluoride Lipid Microspheres
- Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver TumorsRecruitingPhase 2john eisenbreyNCT06261814Written as Sulfur Hexafluoride Lipid Microspheres
- Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast MassesRecruitingPhase 1University of Southern CaliforniaNCT06171607Written as Sulfur Hexafluoride Lipid Microspheres
- Neonatal Brain Ultrasound With CEUS and ElastographyRecruitingPhase 3Turku University HospitalNCT05648812Written as Sulfur Hexafluoride
- CEUS for Blunt Abdominal Trauma in ChildrenRecruitingPhase 4Children's Hospital of PhiladelphiaNCT03490929Written as Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Intravenous Powder for Suspension [LUMASON]
- Contrast Enhanced 3D Echocardiographic Quantification of Right Ventricular Volumes in Repaired CHDCompletedPhase 1/2Nemours Children's ClinicNCT05186415Written as Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON]
- Preterm Neonates Brain Ultrasound With CEUS and ElastographyWithdrawnPhase 3Turku University HospitalNCT05694611Written as Sulfur Hexafluoride
- Pilot Study to Evaluate if Contrast Enhanced Ultrasound (CEUS) Can Predict Treatment Response in Triple Negative Breast Cancer (TNBC) Patients Receiving Combined Chemotherapy and Immune Checkpoint Inhibitors (ICI).WithdrawnEarly Phase 1Milton S. Hershey Medical CenterNCT05957042Written as Lumason
- Contrast Ultrasound for Pediatric Trauma - Comparative Evaluation (CAPTURE Study)CompletedPhase 1/2David MooneyNCT04718441Written as Lumason
- CEUS Evaluation of Hypoxic Ischemic InjuryCompletedPhase 3Children's Hospital of PhiladelphiaNCT03549520Written as Sulfur hexafluoride lipid-type A microspheres
- CEUS Evaluation of Bowel Perfusion in Necrotizing EnterocolitisTerminatedPhase 3Children's Hospital of PhiladelphiaNCT03549507Written as Sulfur hexafluoride lipid-type A microspheres
- BEFAST (Bubble-Enhanced FAST) for the Evaluation of Solid Organ InjuryCompletedPhase 4Emory UniversityNCT05025449Written as Bubble-Enhanced FAST (BEFAST)
- Evaluation of the Efficacy of Contrast Enhanced Ultrasound Compared to MRI for Differentiation of Hepatic LesionsCompletedPhase 4Indiana UniversityNCT03652636Written as Sulfur Hexafluoride Microspheres
- Contrast-Enhanced Ultrasound and Shear Wave Elastography for the Treatment of LymphedemaCompletedPhase 1Mayo ClinicNCT05613946Written as Lumason
- Contrast Enhanced Ultrasound in COVID-19CompletedPhase 3Children's Hospital of PhiladelphiaNCT04640038Written as Sulfur hexafluoride lipid-type A microspheres
See all 38 studies that test Sulfur Hexafluoride →
Given in every arm · 5 — Sulfur Hexafluoride is usual care beside what is tested
- NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain TumorsRecruitingPhase 1Children's National Research InstituteNCT07664176Written as Lumason
- Safety And Effectiveness Of NaviFUS System With Bevacizumab In Recurrent GlioblastomaNot yet recruitingNot applicableUniversity of CincinnatiNCT07274787Written as Lumason
- Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)SuspendedPhase 1/2NaviFUS CorporationNCT06329570Written as Lumason
- Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung DisordersTerminatedEarly Phase 1Thunder Bay Regional Health Research InstituteNCT02748798Written as SF6
- Contrast-Enhanced Ultrasound in Diagnosing Patients With Liver Cancer Undergoing Yttrium-90 RadioembolizationWithdrawnNot applicableUniversity of Southern CaliforniaNCT03300401Written as Sulfur Hexafluoride Lipid Microspheres
Codes
What other systems call Sulfur Hexafluoride · ClinicalTrials.gg INT008258
- MeSH (NLM) D013459Sulfur HexafluorideConfirmed NLM, Wikidata
- UNII (FDA) WS7LR3I1D6SULFUR HEXAFLUORIDEConfirmed FDA, NLM, Wikidata
- RxNorm 1599276Confirmed FDA, Wikidata
- Wikidata Q279055sulfur hexafluorideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C84187Sulfur HexafluorideOne source FDA
- DrugBank DB11104One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D013459 | Sulfur Hexafluoride | Confirmed NLM, Wikidata |
| UNII (FDA) | WS7LR3I1D6 | SULFUR HEXAFLUORIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1599276 | — | Confirmed FDA, Wikidata |
| Wikidata | Q279055 | sulfur hexafluoride | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C84187 | Sulfur Hexafluoride | One source FDA |
| DrugBank | DB11104 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.